News 07.10.2017 Broad Institute of MIT and Harvard joins discussions to create worldwide CRISPR-Cas9 licensing pool If other key patent holders join, pool would expand access and streamline non-exclusive licensing for commercial use Licensing data, tools, and technologies Licensing CRISPR Read more
Blog 12.16.2016 Licensing of IP to maximize public benefit How should academic and non-profit institutions make IP licensing decisions to best fulfill their responsibilities to the public? Industrial partnerships Licensing data, tools, and technologies Licensing Read more
Information about licensing CRISPR systems, including for clinical use Broad Institute, MIT and Harvard share the goal of developing innovative technologies such as CRISPR genome editing tools and promoting its translation into therapies to benefit patients. Read more about Information about licensing CRISPR systems, including for clinical use